(Q37600500)

21 August 2017

title

Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery (English)

1 reference

21 August 2017

1 reference

Robert E Elliott

1

1 reference

21 August 2017

Chad Carlson

2

1 reference

21 August 2017

Stephen P Kalhorn

3

1 reference

21 August 2017

Yaron A Moshel

4

1 reference

21 August 2017

Howard L Weiner

5

1 reference

21 August 2017

Orrin Devinsky

6

1 reference

21 August 2017

Werner K Doyle

7

1 reference

21 August 2017

publication date

19 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

16

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

454-460

1 reference

Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Neurological manifestations of tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Developmental outcome after epilepsy surgery in infancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Cognitive and behavioral correlates of tuberous sclerosis complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Tuberous sclerosis complex and the ketogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagal nerve stimulation in tuberous sclerosis complex patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Epilepsy surgery and tuberous sclerosis complex: special considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Epilepsy surgery in tuberous sclerosis: the Dutch experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Long-term outcome of epilepsy surgery in patients with tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Efficacy of vagal nerve stimulation in children with medically refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Subpectoral implantation of the vagus nerve stimulator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Neuropsychological effects of seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Cognitive decline in severe intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vigabatrin for tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Cognitive function in preschool children after epilepsy surgery: rationale for early intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Quality of life after vagus nerve stimulation for intractable epilepsy: is seizure control the only contributing factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Durability of antidepressant response to vagus nerve stimulation (VNS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Complications of chronic vagus nerve stimulation for epilepsy in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

Tuberous sclerosis. Surgical therapy for seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.08.018

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2009.08.018

1 reference

21 August 2017

1 reference